Methylation Alterations of Imprinted Genes in Different Placental Diseases

Overview

Journal Clin Epigenetics

Publisher Biomed Central

Specialty Genetics

Date 2024 Sep 18

PMID 39294759

Authors

Xuwei Wang

Yunyun Liu

Yuying Wu

Chunxi Lin

Si Yang

Yuhan Yang

Dunjin Chen

Bolan Yu

Affiliations

Soon will be listed here.

Abstract

Background: Imprinted genes play important functions in placentation and pregnancy; however, research on their roles in different placental diseases is limited. It is believed that epigenetic alterations, such as DNA methylation, of placental imprinting genes may contribute to the different pathological features of severe placental diseases, such as pre-eclampsia (PE) and placenta accreta spectrum disorders (PAS).

Results: In this study, we conducted a comparative analysis of the methylation and expression of placental imprinted genes between PE and PAS using bisulfite sequencing polymerase chain reaction (PCR) and quantitative PCR, respectively. Additionally, we assessed oxidative damage of placental DNA by determining 8-hydroxy-2'-deoxyguanosine levels and fetal growth by determining insulin-like growth factor 2 (IGF2) and cortisol levels in the umbilical cord blood using enzyme-linked immunosorbent assay. Our results indicated that methylation and expression of potassium voltage-gated channel subfamily Q member 1, GNAS complex locus, mesoderm specific transcript, and IGF2 were significantly altered in both PE and PAS placentas. Additionally, our results revealed that the maternal imprinted genes were significantly over-expressed in PE and significantly under-expressed in PAS compared with a normal pregnancy. Moreover, DNA oxidative damage was elevated and positively correlated with IGF2 DNA methylation in both PE and PAS placentas, and cortisol and IGF2 levels were significantly decreased in PE and PAS.

Conclusions: This study suggested that DNA methylation and expression of imprinted genes are aberrant in both PE and PAS placentas and that PE and PAS have different methylation profiles, which may be linked to their unique pathogenesis.

References

Li E, Beard C, Jaenisch R . Role for DNA methylation in genomic imprinting. Nature. 1993; 366(6453):362-5. DOI: 10.1038/366362a0. View

Ferguson K, Meeker J, McElrath T, Mukherjee B, Cantonwine D . Repeated measures of inflammation and oxidative stress biomarkers in preeclamptic and normotensive pregnancies. Am J Obstet Gynecol. 2017; 216(5):527.e1-527.e9. PMC: 5420472. DOI: 10.1016/j.ajog.2016.12.174. View

Constancia M, Kelsey G, Reik W . Resourceful imprinting. Nature. 2004; 432(7013):53-7. DOI: 10.1038/432053a. View

Wu Q, Ni X . ROS-mediated DNA methylation pattern alterations in carcinogenesis. Curr Drug Targets. 2015; 16(1):13-9. DOI: 10.2174/1389450116666150113121054. View

Uuskula L, Mannik J, Rull K, Minajeva A, Koks S, Vaas P . Mid-gestational gene expression profile in placenta and link to pregnancy complications. PLoS One. 2012; 7(11):e49248. PMC: 3492272. DOI: 10.1371/journal.pone.0049248. View

Goh W, Yamamoto S, Thompson K, Bryant-Greenwood G . Relaxin, its receptor (RXFP1), and insulin-like peptide 4 expression through gestation and in placenta accreta. Reprod Sci. 2013; 20(8):968-80. PMC: 3713646. DOI: 10.1177/1933719112472735. View

Sferruzzi-Perri A, Sandovici I, Constancia M, Fowden A . Placental phenotype and the insulin-like growth factors: resource allocation to fetal growth. J Physiol. 2017; 595(15):5057-5093. PMC: 5538190. DOI: 10.1113/JP273330. View

Szyf M . The early-life social environment and DNA methylation. Clin Genet. 2012; 81(4):341-9. DOI: 10.1111/j.1399-0004.2012.01843.x. View

Argyraki M, Damdimopoulou P, Chatzimeletiou K, Grimbizis G, Tarlatzis B, Syrrou M . In-utero stress and mode of conception: impact on regulation of imprinted genes, fetal development and future health. Hum Reprod Update. 2019; 25(6):777-801. DOI: 10.1093/humupd/dmz025. View

10.

Sundrani D, Reddy U, Chavan-Gautam P, Mehendale S, Chandak G, Joshi S . Altered methylation and expression patterns of genes regulating placental angiogenesis in preterm pregnancy. Reprod Sci. 2014; 21(12):1508-17. DOI: 10.1177/1933719114532838. View

11.

Rose A, Herzig S . Metabolic control through glucocorticoid hormones: an update. Mol Cell Endocrinol. 2013; 380(1-2):65-78. DOI: 10.1016/j.mce.2013.03.007. View

12.

Kawabata H, Ono Y, Tamamura N, Oyama K, Ueda J, Sato H . Mutant GNAS limits tumor aggressiveness in established pancreatic cancer via antagonizing the KRAS-pathway. J Gastroenterol. 2022; 57(3):208-220. DOI: 10.1007/s00535-021-01846-4. View

13.

Shen R, Cheng T, Xu C, Yung R, Bao J, Li X . Novel visualized quantitative epigenetic imprinted gene biomarkers diagnose the malignancy of ten cancer types. Clin Epigenetics. 2020; 12(1):71. PMC: 7245932. DOI: 10.1186/s13148-020-00861-1. View

14.

Liang L, Guo W, Esquiliano D, Asai M, Rodriguez S, Giraud J . Insulin-like growth factor 2 and the insulin receptor, but not insulin, regulate fetal hepatic glycogen synthesis. Endocrinology. 2009; 151(2):741-7. PMC: 2817628. DOI: 10.1210/en.2009-0705. View

15.

Villalpando-Rodriguez G, Gibson S . Reactive Oxygen Species (ROS) Regulates Different Types of Cell Death by Acting as a Rheostat. Oxid Med Cell Longev. 2021; 2021:9912436. PMC: 8380163. DOI: 10.1155/2021/9912436. View

16.

Hussain T, Murtaza G, Metwally E, Kalhoro D, Kalhoro M, Rahu B . The Role of Oxidative Stress and Antioxidant Balance in Pregnancy. Mediators Inflamm. 2021; 2021:9962860. PMC: 8490076. DOI: 10.1155/2021/9962860. View

17.

He J, Zhang A, Fang M, Fang R, Ge J, Jiang Y . Methylation levels at IGF2 and GNAS DMRs in infants born to preeclamptic pregnancies. BMC Genomics. 2013; 14:472. PMC: 3723441. DOI: 10.1186/1471-2164-14-472. View

18.

Kurakami K, Norota I, Nasu F, Ohshima S, Nagasawa Y, Konno Y . KCNQ1 is internalized by activation of α adrenergic receptors. Biochem Pharmacol. 2019; 169:113628. DOI: 10.1016/j.bcp.2019.113628. View

19.

Cattanach B, Kirk M . Differential activity of maternally and paternally derived chromosome regions in mice. Nature. 1985; 315(6019):496-8. DOI: 10.1038/315496a0. View

20.

Mamsen L, Bjorvang R, Mucs D, Vinnars M, Papadogiannakis N, Lindh C . Concentrations of perfluoroalkyl substances (PFASs) in human embryonic and fetal organs from first, second, and third trimester pregnancies. Environ Int. 2019; 124:482-492. DOI: 10.1016/j.envint.2019.01.010. View